Pluristem Therapeutics Inc (PSTI)

[Scott999]

Was thinking a little more on the ARS study and the 50% survival of the non treated group. I just realized that theoretically, 50% of the TREATED group should have survived as well even if treatment did nothing at all. So wouldn't that put us at just 10% better than the placebo?

Something with my numbers doesn't seem right to me. Maybe someone can help. Of course, this is being very simplistic not taking all results into account, but just something to ponder. That's why we need numbers involved that give us statistically significant results. And this thought would also have to be applied to competitors results as well.

The wait to get this ball rolling is painful to say the least. Once initiated, it's out of the hands of Pluristem's hands, so timelines should be met.